All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Treatment of coronary in-stent restenosis: a systematic review

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F18%3A00068687" target="_blank" >RIV/00159816:_____/18:00068687 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/18:00104044 RIV/00843989:_____/18:E0107017

  • Result on the web

    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895957/" target="_blank" >https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895957/</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.11909/j.issn.1671-5411.2018.02.007" target="_blank" >10.11909/j.issn.1671-5411.2018.02.007</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Treatment of coronary in-stent restenosis: a systematic review

  • Original language description

    Coronary stent implantation has significantly improved percutaneous coronary intervention and enabled the management of early complications of plain balloon angioplasty. However, a new complication has accompanied these improvements: in-stent restenosis (ISR) arising from neointimal hyperplasia. ISR after coronary angioplasty is currently one of the main limitations of this method, leading to the recurrence of exertional angina pectoris or acute coronary syndromes. The clinical incidence of ISR after bare-metal stent (BMS) implantation is approximately 20%-35%. The use of drug-eluting stents (DES) has led to a further decrease in the occurrence of ISR to 5%-10%. Evidence resulting from controlled clinical studies suggests that DES and drug-eluting balloon catheters (DEB) provide the best clinical and angiographic results in the treatment of ISR. We undertook a systematic review of the pathophysiology, diagnostics and treatment options for BMS- and DES-ISR. We discuss recent randomised studies, comparing different DES or DEB used for BMS or DES-ISR treatment, as well as the use of new biovascular scafolds and the topic of scafold restenosis.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    JOURNAL OF GERIATRIC CARDIOLOGY

  • ISSN

    1671-5411

  • e-ISSN

  • Volume of the periodical

    15

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    CN - CHINA

  • Number of pages

    12

  • Pages from-to

    173-184

  • UT code for WoS article

    000429624200007

  • EID of the result in the Scopus database